-controlling interests 8,638 138,189 221,867 48,311 Profit (loss) to owners of parent (578,525) (1,179,473) (2,156,485) (354,355) 2017 % 1 Jan - 30 Sep 2018 (9 mths) %Consolidated statement of income 2015 % 2016

made from trade receivables as detailed in the financial statement of WPS as of 30 November 2018. 3. General characteristics of the transaction and transaction value and details of the asset disposal 3.1

value according to the financial statements as at 31 December 2019 of MV. Summary of financial statement of Medical Vision Company Limited as of 31 December 2019 Item Value (Baht) Total Assets

Statement 19 Table 8 Debt Profile 20 Table 9 Joint Ventures Performance 20 Table 10 IVL Consolidated Statement of Income 21 Table 11 IVL Consolidated Statement of Financial Position 22 Table 12 2019 Planned

price and the market price and plus with the number of offer for sale shares as the expense in the profit and loss statement and record the premium on shares from the Share-based Payment rule in the

Shareholder No.1/2019 Agenda 2 To acknowledge the report on the Company’s operating result for the year 2019 Agenda 3 To acknowledge interim payment Agenda 4 To consider and approve the financial statement of

the consolidated financial statement of the Company for the nine-month period ended 30 September 2019, audited by the certified auditors of the Company, the details in relation to the calculation are as

ส่วนท่ีเก่ียวกบัการใหค้ าแนะน าเบ้ืองตน้เพื่อใหลู้กคา้เขา้ใจ ความส าคญัในการจดัสรรและก าหนดสัดส่วนการลงทุนหรือการท าธุรกรรมในผลิตภณัฑใ์นตลาดทุน ท่ีเหมาะสม (basic asset allocation) ใหใ้ชบ้งัคบัตั้งแต่

share based on the lastest financial statement of GS that audited by auditor. • The second additional share purchase: The Company agrees to purchase 69,144 GS’s shares from Mr.Suwicha Panichpol There is

metre per day. And b) GS has earning per share not less than Baht 65 per share based on the lastest financial statement of GS that audited by auditor. • The second additional share purchase: The Company